Blood chemokine levels are markers of disease activity but not predictors of remission in early rheumatoid arthritis

Autor: Aldridge, J., Lundell, A. C., Andersson, K., Mark, L., Hetland, M. Lund, Østergaard, M., Uhlig, T., Heiberg, M. Schrumpf, Haavardsholm, E. A., Nurmohamed, M., Lampa, J., Nordström, D., Hørslev-Petersen, K., Gudbjornsson, B., Gröndal, G., van Vollenhoven, R., Rudin, A.

Publikováno v: Clinical and Experimental Rheumatology, 40(7), 1393-1402. Clinical and Experimental Rheumatology S.A.S.
Clinical and experimental rheumatology, 40(7), 1393-1402. Clinical and Experimental Rheumatology S.A.S.
Aldridge, J, Lundell, A C, Andersson, K, Mark, L, Hetland, M L, Østergaard, M, Uhlig, T, Heiberg, M S, Haavardsholm, E A, Nurmohamed, M, Lampa, J, Nordström, D, Hørslev-Petersen, K, Gudbjornsson, B, Gröndal, G, van Vollenhoven, R & Rudin, A 2022, ' Blood chemokine levels are markers of disease activity but not predictors of remission in early rheumatoid arthritis ', Clinical and Experimental Rheumatology, vol. 40, no. 7, pp. 1393-1402 . https://doi.org/10.55563/clinexprheumatol/idogmj

Objective In early rheumatoid arthritis (eRA) plasma levels of specific chemokines have been shown to correlate with disease activity. However, it is unclear whether pre-treatment chemokine levels can predict disease remission at week 24, and it is n

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efb9c62ef59516aa1c22c4e92de501a8
https://doi.org/10.55563/clinexprheumatol/idogmj

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

EXPOSURE TO SPECIFIC TUMOR NECROSIS FACTOR INHIBITORS AND RISK OF DEMYELINATING AND INFLAMMATORY NEUROPATHY IN PATIENTS WITH INFLAMMATORY ARTHRITIS. A COLLABORATIVE OBSERVATIONAL STUDY ACROSS FIVE NORDIC RHEUMATOLOGY REGISTERS

Autor: Delcoigne, B., Kopp, T. I., Arkema, E., Hellgren, K., Provan, S. Aarrestad, Relas, H., Aaltonen, K., Trokovic, N., Gudbjornsson, B., Gröndal, G., Kristianslund, E., Dreyer, L., Askling, J.

Publikováno v: Delcoigne, B, Kopp, T I, Arkema, E, Hellgren, K, Provan, S A, Relas, H, Aaltonen, K, Trokovic, N, Gudbjornsson, B, Gröndal, G, Kristianslund, E, Dreyer, L & Askling, J 2022, ' EXPOSURE TO SPECIFIC TUMOR NECROSIS FACTOR INHIBITORS AND RISK OF DEMYELINATING AND INFLAMMATORY NEUROPATHY IN PATIENTS WITH INFLAMMATORY ARTHRITIS. A COLLABORATIVE OBSERVATIONAL STUDY ACROSS FIVE NORDIC RHEUMATOLOGY REGISTERS ', Annals of the Rheumatic Diseases, vol. 81, no. Suppl. 1, OP0060 , pp. 41 . https://doi.org/10.1136/annrheumdis-2022-eular.2866

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::dcbfecff9a60be67813db9d6f1440ed9
https://vbn.aau.dk/da/publications/35c775c1-ef04-4cb7-88d1-457ee0cbfdc6

A MULTICENTER RANDOMIZED STUDY IN EARLY RHEUMATOID ARTHRITIS TO COMPARE ACTIVE CONVENTIONAL THERAPY VERSUS THREE BIOLOGICAL TREATMENTS: 24 WEEK EFFICACY RESULTS OF THE NORD-STAR TRIAL

Autor: Kim Hørslev-Petersen, Merete Lund Hetland, Haavardsholm, E. A., Rudin, A., Nordstrom, D., Nurmohamed, M., Gudbjornsson, B., Lampa, J., Till Uhlig, Gröndal, G., Østergaard, M., Heiberg, M., Twisk, J., Krabbe, S., Lend, K., Olsen, I., Lindqvist, J., Ekwall, A. K. H., Grøn, Kathrine L., Kapetanovic, Meliha C., Francesca Faustini, Riitta Tuompo, Tove Lorenzen, Giovanni Cagnotto, Baecklund, E., Oliver Hendricks, Vedder, D., Tuulikki Sokka-isler, Tomas Husmark, Maud-Kristine Aga Ljosa, Eli Brodin, Torkell Ellingsen, Annika Soderbergh, Milad Rizk, Å, Reckner, Larsson, P., Uhrenholt, L., Just, S. A., David Stevens, Tb, Laurberg, Gunnstein Bakland, Vollenhoven, Ronald F.

Publikováno v: Hørslev-Petersen, K, Hetland, M L, Haavardsholm, E A, Rudin, A, Nordstrom, D, Nurmohamed, M, Gudbjornsson, B, Lampa, J, Uhlig, T, Gröndal, G, Østergaard, M, Heiberg, M, Twisk, J, Krabbe, S, Lend, K, Olsen, I, Lindqvist, J, Ekwall, A K H, Grøn, K L, Kapetanovic, M C, Faustini, F, Tuompo, R, Lorenzen, T, Cagnotto, G, Baecklund, E, Hendricks, O, Vedder, D, Sokka-isler, T, Husmark, T, Ljosa, M-K A, Brodin, E, Ellingsen, T J, Soderbergh, A, Rizk, M, Reckner, Å, Larsson, P, Uhrenholt, L, Just, S A, Stevens, D, Laurberg, TB, Bakland, G & van Vollenhoven, R F 2020, ' A MULTICENTER RANDOMIZED STUDY IN EARLY RHEUMATOID ARTHRITIS TO COMPARE ACTIVE CONVENTIONAL THERAPY VERSUS THREE BIOLOGICAL TREATMENTS: 24 WEEK EFFICACY RESULTS OF THE NORD-STAR TRIAL ', EULAR 2020, 03/06/2020-06/06/2020 .
University of Southern Denmark
Hørslev-Petersen, K, Hetland, M L, Haavardsholm, E A, Rudin, A, Nordstrom, D, Nurmohamed, M, Gudbjornsson, B, Lampa, J, Uhlig, T, Gröndal, G, Østergaard, M, Heiberg, M, Twisk, J, Krabbe, S, Lend, K, Olsen, I, Lindqvist, J, Ekwall, A K H, Grøn, K L, Kapetanovic, M C, Faustini, F, Tuompo, R, Lorenzen, T, Cagnotto, G, Baecklund, E, Hendricks, O, Vedder, D, Sokka-isler, T, Husmark, T, Ljosa, M-K A, Brodin, E, Ellingsen, T J, Soderbergh, A, Rizk, M, Reckner, A, Larsson, P, Uhrenholt, L, Just, S A, Stevens, D, Laurberg, TB, Bakland, G & van Vollenhoven, R F 2020, ' A MULTICENTER RANDOMIZED STUDY IN EARLY RHEUMATOID ARTHRITIS TO COMPARE ACTIVE CONVENTIONAL THERAPY VERSUS THREE BIOLOGICAL TREATMENTS: 24 WEEK EFFICACY RESULTS OF THE NORD-STAR TRIAL ', Annals of the Rheumatic Diseases, vol. 79, no. suppl. 1, pp. 13-16 .

OP0018 (2020) A MULTICENTER RANDOMIZED STUDY IN EARLY RHEUMATOID ARTHRITIS TO COMPARE ACTIVE CONVENTIONAL THERAPY VERSUS THREE BIOLOGICAL TREATMENTS: 24 WEEK EFFICACY RESULTS OF THE NORD-STAR TRIAL M. L. Hetland1, E. A. Haavardsholm1, A. Rudin1, D. N

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::3038e001b649cd9d966f7a41b37e874b
https://portal.findresearcher.sdu.dk/da/publications/57bffce4-1617-49c3-93d6-a33f0065d270

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.